"Why maxing out your credit card to buy $KTOV cannot possibly go wrong" -- a thread by your Divorced Trader

Kitov Pharma has until July 6th to close at/above $1 for ten consecutive days, meaning this $1 close streak must start in late June.

If this does not happen organically, Kitov will likely do a reverse split or be delisted. Both bad. https://www.globenewswire.com/news-release/2020/01/08/1967750/0/en/Kitov-Pharma-Granted-Additional-180-day-Extension-by-Nasdaq-to-Comply-with-Bid-Price-Rule.html

If Kitov maintains its current growth rate (which I roughly calculated using the below trend line and an online graphing calculator) it will be worth $1/share on July 17th.

That trend line is cool, but a bullshit crapshoot. Who invests based off a trend line? Idiots like me.

Who doesn't? Morgan Stanley, who increased their stake in Kitov by 787.47% on May 15th. https://fintel.io/so/us/ktov/morgan-stanley

So Morgan Stanley increased their shares of Kitov by over 7x only 52 days before the NASDAQ compliance $1 deadline? Yes.

"Why would they do something so risky? There could be a reverse split or the stock could be delisted as a whole!"

Because they were told something.

There is plenty of wiggle room for $KTOV to increase 182% by late June.

The catalyst are there. Kitov will present at ASCO this Friday. Below is their drug pipeline. Maybe more Consensi launch info with more numbers.

This is very possible, and Morgan Stanley thinks so too.